Skip to main content
Clinical Trials/NL-OMON28732
NL-OMON28732
Completed
Not Applicable

Evaluation of the effects of a community pharmacist-led medication review on patient reported outcomes (PROM) as measured with a questionnaire: a pilot randomised controlled trial

Radboud university medical center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands0 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
adverse drug reactions (ADRs), side effects of drugs, medication adherence (MARS), beliefs about medicines necessity and concerns (BMQ), self efficacy (MUSE)
Sponsor
Radboud university medical center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Radboud university medical center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands

Eligibility Criteria

Inclusion Criteria

  • Patients eligible for a community pharmacist\-led medication review according to the guidelines (use of 5 or more prescribed chronic systemic drugs).
  • Other criteria to achieve the intended study population of 20 patients per pharmacy to be determined by the pharmacist, like: age over 65, specific chronic diseases, general practitioner (GP) of the patient.

Exclusion Criteria

  • To be assessed by the community pharmacists considering:
  • \- cognitive or communication impairments;

Outcomes

Primary Outcomes

Not specified

Similar Trials